首页> 外文期刊>Journal of medicinal food >Effects of Herbal Formulas Bojungikgi-tang and Palmijihwang-hwan on Inflammation in RAW 264.7 Cells and the Activities of Drug-Metabolizing Enzymes in Human Hepatic Microsomes
【24h】

Effects of Herbal Formulas Bojungikgi-tang and Palmijihwang-hwan on Inflammation in RAW 264.7 Cells and the Activities of Drug-Metabolizing Enzymes in Human Hepatic Microsomes

机译:草药Bojungikgi-Tang和Palmiihwang-Hwan对原始264.7细胞炎症的影响及人肝微粒体中药物代谢酶活性

获取原文
获取原文并翻译 | 示例
           

摘要

In the present study, Bojungikgi-tang (BJIKT: Buzhongyiqi-tang, Hochuekki-to) and Palmijihwang-hwan (PMJHH: Baweidihuang-wan, Hachimijio-gan), traditional herbal formulas, investigated anti-inflammatory efficacies in murine macrophage cell line and the influence on the activities of drug-metabolizing enzymes (DMEs). The anti-inflammatory potentials of the herbal formulas were evaluated to inhibit the production of the inflammatory mediators and cytokines and the protein expression of inducible nitric oxide and cyclooxygenase-2 (COX-2) in lipopolysaccharide (LPS)-treated RAW 264.7 cells. The activities of the major human DMEs, cytochrome P450 isozymes (CYP450s) and UDP-glucuronosyltransferase isozymes (UGTs), were measured by in vitro enzyme assay systems. BJIKT and PMJHH significantly suppressed the prostaglandin E-2 (PGE(2)) production (IC50=317.3 and 282.2g/mL, respectively) and the protein expression of COX-2 in LPS-treated RAW264.7 cells. On the human microsomal DMEs, BJIKT inhibited the activities of CYP1A2 (IC50=535.05g/mL), CYP2B6 (IC50 1000g/mL), CYP2C9 (IC50=800.78g/mL), CYP2C19 (IC50=563.11g/mL), CYP2D6 (IC50 1000g/mL), CYP2E1 (IC50 1000g/mL), CYP3A4 (IC50=879.60g/mL), UGT1A1 (IC50 1000g/mL), and UGT1A4 (IC50 1000g/mL), but it showed no inhibition of the UGT2B7 activity at doses less than 1000g/mL. PMJHH inhibited the CYP2D6 activity (IC50=280.89g/mL), but IC50 values of PMJHH exceeded 1000g/mL on the activities of CYP1A2, CYP2C19, CYP2E1, and CYP3A4. At concentrations less than 1000g/mL, PMJHH did not affect the activities of CYP2B6, CYP2C9, UGT1A1, UGT1A4, and UGT2B7. The results indicate that both BJIKT and PMJHH may be potential candidates to prevent and treat PGE(2)- and COX-2-mediated inflammatory diseases. In addition, this study will expand current knowledge about herb-drug interactions by BJIKT and PMJHH.
机译:在目前的研究中,Bojungikgi-Tang(Bjikt:Buzhongyiqi-Tang,Hochuekki-to)和Palmihwang-Hwan(PMJHH:Baweidihuang-Wan,Hachimijio-GaN),传统草药公式,研究了鼠巨噬细胞系中的抗炎效果对药物代谢酶活性(DMES)的影响的影响。评估草药公式的抗炎电位,以抑制脂多糖(LPS)-Treated 264.7细胞中诱导型介质和细胞因子的产生和诱导型一氧化物和环氧化酶-2(COX-2)的蛋白质表达。通过体外酶测定系统测量主要人体DMES,细胞色素P450同工酶(CYP450)和UDP-葡糖醛糖核糖基甲基转移酶同工酶(UGTS)的活性。 Bjikt和PMJHH显着抑制了前列腺素E-2(PGE(2))生产(分别为1P50 = 317.3和282.2g / ml,COX-2中的蛋白质表达在LPS处理的RAW264.7细胞中。在人微粒体DMES上,Bjikt抑制CYP1A2(IC50 = 535.05g / mL)的活性,CYP2B6(IC50> 1000g / mL),CYP2C9(IC50 = 800.78g / mL),CYP2C19(IC50 = 563.11g / mL) ,CYP2D6(IC50& 1000g / ml),CYP2E1(IC50& 1000g / mL),CYP3A4(IC50 = 879.60g / mL),UGT1A1(IC50> 1000g / mL)和UGT1A4(IC50> 1000g / ml ),但它显示出在小于1000g / mL的剂量下对UGT2B7活性的抑制。 PMJHH抑制CYP2D6活性(IC50 = 280.89g / mL),但CYP1A2,CYP2C19,CYP2E1和CYP3A4的活性,PMJH​​H的IC 50值超过1000g / mL。在小于1000g / ml的浓度下,PMJH​​H不影响CYP2B6,CYP2C9,UGT1A1,UGT1A4和UGT2B7的活性。结果表明,Bjikt和PMJHH都可能是预防和治疗PGE(2) - 和COX-2介导的炎性疾病的潜在候选者。此外,本研究将扩大Bjikt和PMJHH对草药互动的现有知识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号